Related Experiment Video
Updated: May 29, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
Heater probe thermocoagulation for high-risk patients who show rebleeding from peptic ulcers
1Division of Gastroenterology, Department of Medicine, Buddhist Dalin Tzu Chi General Hospital, Chia-Yi and Buddhist Tzu Chi University, School of Medicine, Hwalien, Taiwan.
Aim:
To investigate whether heater probe therapy is effective for patients showing rebleeding from peptic ulcers.
Methods:
We retrospectively reviewed the case profiles in our previous studies on endoscopic therapy for high-risk patients with peptic ulcer bleeding in the past two decades. We analysed the outcomes of 191 patients who showed rebleeding after initial endoscopic haemostasis and received endoscopic therapy with heater probe thermocoagulation. .
Results:
A total of 191 patients showing rebleeding received heater probe thermocoagulation. After re-therapy, 158 patients (82.7%) achieved ultimate haemostasis. Twenty-five of the 33 patients who failed to achieve haemostasis received surgical intervention. Ten patients (5.2%) died within 1 month after re-therapy.
Conclusion:
Heater probe thermocoagulation can be used as the first choice for management of patients showing rebleeding after initial endoscopic therapy.
More Related Videos
05:43Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling
Published on: April 19, 2024
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Decreased Body Temperature
Anticoagulant Drugs: Low-Molecular-Weight Heparins